Category Pharmaceutical Industry

North Dakota to Receive Nearly $3 Million in Whistleblower Lawsuit [Legal Monitor Worldwide]

Dec31

The state of North Dakota will be receiving nearly $3 million for its state Medicaid program as part of a whistleblower settlement between the federal government and a major pharmaceutical company.A Tuesday release from the North Dakota Department of Human Services announced that the state Medicaid program will receive about $2.99 million. The money comes […]

IGI Laboratories, Inc. Completes Its Sixth ANDA Filing For 2013 Under Joint Drug Development And Commercialization Agreement

Dec31

BUENA, N.J., Dec. 31, 2013 /PRNewswire/ IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it executed a license, development, supply and marketing agreement with a large multi-national pharmaceutical company. In accordance with the confidentiality agreement in place, the name of the company remains undisclosed. The agreement designates […]

Newly identified immune receptor may activate B cells in autoimmunity

Dec30

By a News Reporter-Staff News Editor at Clinical Trials Week BIRMINGHAM, Ala. – A newly identified immune protein influences each person’s response to vaccines and risk for autoimmune diseases like lupus and multiple sclerosis, according to a study published by researchers from the School of Medicine at the University of Alabama at Birmingham in the […]

Tetralogic Pharmaceuticals Corp. Files SEC Form 424B4, Prospectus [Rule 424(B)(4)] (Dec. 12, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Tetralogic Pharmaceuticals Corp. (Form 424B4) was posted on December 12, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There were 8 documents filed with […]

Valeant Pharmaceuticals International, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Dec. 13, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Valeant Pharmaceuticals International, Inc. (Form 4) was posted on December 13, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There was one document filed […]

Global Animal and Human Healthcare Thought Leaders Gather for Summit in Seattle

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week Animal and human healthcare thought leaders gathered in Seattle on Wednesday, December 11, for the first annual “Translational and Comparative Research Summit.” The Summit raised awareness in the medical, research and investment communities about species-spanning approaches to healthcare, which are leading to breakthrough therapies and […]

Spectrum Pharmaceuticals Inc. Files SEC Form CT ORDER, Confidential Treatment Order (Dec. 18, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Spectrum Pharmaceuticals Inc. (Form CT ORDER) was posted on December 18, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There was one document filed […]

Progen Pharmaceuticals Ltd Files SEC Form 20-F, Annual And Transition Report of Foreign Private Issuers [Sections 13 Or 15(D)] [Amend] (Dec. 12, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Progen Pharmaceuticals Ltd (Form 20-F) was posted on December 12, 2013.The SIC code for this company is 2833, Medicinal Chemicals and Botanical Products.There were 6 […]

Actinium Announces Voting Results from Its Annual Shareholder Meeting

Dec30

Results Indicate Strong Support for Board of Directors and Company Proposals NEW YORK(BUSINESS WIRE) Actinium Pharmaceuticals, Inc. (OTCQB:ATNM.OB) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced the voting results from its annual general meeting of the Company’s shareholders (the “meeting”) which was held on […]

Ligand Pharmaceuticals Inc. Files SEC Form CT ORDER, Confidential Treatment Order (Dec. 16, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Ligand Pharmaceuticals Inc. (Form CT ORDER) was posted on December 16, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There was one document filed […]